CA 125 in the management of endometriosis

This publication has 11 references indexed in Scilit:

• Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa?
  Fertility and Sterility, 1992
• CA 125 concentrations in ovarian ‘chocolate’ cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum
  Human Reproduction, 1992
• Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain
  Fertility and Sterility, 1991
• Clinical usefulness of CA-125 levels in the menstrual discharge in patients with endometriosis
  Fertility and Sterility, 1990
• Deeply infiltrating pelvic endometriosis: histology and clinical significance
  Fertility and Sterility, 1990
• CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1989
• The CA 125 tumour-associated antigen: a review of the literature
  Human Reproduction, 1989
• Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery
  Fertility and Sterility, 1988
• Serum CA-125 antigen levels increase during menses
  American Journal of Obstetrics and Gynecology, 1987
• Biochemical Characterization of Peritoneal Fluid in Women during the Menstrual Cycle*
  Journal of Clinical Endocrinology & Metabolism, 1980